Search
Korro Bio Inc
KRROAdd to Watchlist
13.280USD
0.0000.00%
Close 08-14 16:00（ET）Quotes delayed by 15 min
195.56MMarket Cap
LossP/E TTM
Forecast
Currency: USD Updated: 2026-08-14The current earnings forecast score of Korro Bio Inc is 8.20, ranking 159 out of 387 in the Biotechnology & Medical Research industry. The average price target is 9.50, with a high of 147.00 and a low of 7.00.
Analyst Rating
Based on
12
analysts
Buy
Current Rating
20.000
Target Price
+50.60%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
497
Total
6
Median
7
Average
Company name
Ratings
Analysts
Korro Bio Inc
KRRO
12
Beigene Ltd
ONC
28
argenx SE
ARGX
28
Ionis Pharmaceuticals Inc
IONS
25
IQVIA Holdings Inc
IQV
24
Kymera Therapeutics Inc
KYMR
23
1
2
3
...
100
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Korro Bio Inc's expected revenue for the next quarter?
Korro Bio Inc's expected revenue is 250.00K.
What is Korro Bio Inc's price target?
Analysts forecast that Korro Bio Inc's price target is USD 9.50, with the highest forecast at USD 147.00 and the lowest forecast at USD 7.00.
How have Korro Bio IncKRRO's recent earnings per share performed?
The market expectation was USD -1.07, while Korro Bio IncKRRO's earnings per share (EPS) for the previous quarter was USD -1.69. EPS for the next quarter is expected at USD -1.33.
What is the analyst rating for Korro Bio Inc?
Based on the ratings of Korro Bio Inc's stock from 12 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.